Detalhe da pesquisa
1.
A T-cell antigen atlas for meningioma: novel options for immunotherapy.
Acta Neuropathol
; 146(2): 173-190, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37368072
2.
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.
J Neurooncol
; 160(2): 299-310, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36355258
3.
Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.
Int J Cancer
; 145(1): 242-253, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30549269
4.
Transcriptional control of O6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma.
J Neurochem
; 144(6): 780-790, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29480969
5.
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy.
Acta Neuropathol
; 135(6): 923-938, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29557506
6.
Integrin control of the transforming growth factor-ß pathway in glioblastoma.
Brain
; 136(Pt 2): 564-76, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23378223
7.
Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models.
Transl Oncol
; 28: 101607, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36571986
8.
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition.
Acta Neuropathol Commun
; 11(1): 41, 2023 03 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36915128
9.
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.
Neuro Oncol
; 25(11): 2001-2014, 2023 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37335916
10.
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells.
J Neurochem
; 122(2): 444-55, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22564186
11.
Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo.
Neurooncol Adv
; 4(1): vdac148, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36212740
12.
CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner.
Cell Death Discov
; 8(1): 341, 2022 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35906203
13.
Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma.
Mol Ther Oncolytics
; 20: 166-174, 2021 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-33575479
14.
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.
Cell Death Dis
; 12(10): 885, 2021 09 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34584066
15.
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
J Immunother Cancer
; 9(4)2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33858848
16.
Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation.
Mol Cancer Ther
; 19(6): 1328-1339, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32371586
17.
Interferon-ß sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02.
Oncol Lett
; 19(4): 2649-2656, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32218815
18.
Interferon-ß exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity.
Neurooncol Adv
; 2(1): vdaa043, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32642697
19.
Immunocytokines are a promising immunotherapeutic approach against glioblastoma.
Sci Transl Med
; 12(564)2020 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33028706
20.
Therapeutic Targeting of TGFß Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas.
Clin Cancer Res
; 25(23): 7189-7201, 2019 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31530630